Does Birthplace Independently Predict Human Papillomavirus Vaccine Initiation?
نویسندگان
چکیده
منابع مشابه
Quadrivalent human papillomavirus vaccine.
The lifetime risk of human papillomavirus (HPV) infection exceeds 50%. HPV infection causes >550,000 cases of cervical and anogenital cancer worldwide annually. Infection also causes precancerous lesions and genital warts. HPV types 16 and 18 cause approximately 70% of HPV-related cancers, and HPV types 6 and 11 cause approximately 90% of cases of genital warts. A quadrivalent vaccine for HPV t...
متن کاملDoes framing human papillomavirus vaccine as preventing cancer in men increase vaccine acceptability?
BACKGROUND Human papillomavirus (HPV) vaccine is now approved for use in males in the United States to prevent genital warts. We conducted an experiment to see whether framing HPV vaccination as also preventing cancer in men would increase men's vaccination willingness. METHODS We conducted an online survey in January 2009 with a national sample of men ages 18 to 59 years who self-identified ...
متن کاملHuman papillomavirus vaccine and pregnancy.
UNLABELLED QUESTION A: patient of mine who recently learned she was 6 weeks pregnant had received the recombinant human papillomavirus (HPV) quadrivalent vaccine at 4 weeks of gestation. She is quite worried about how this will affect her baby. What is known about the safety of the HPV vaccine during pregnancy? ANSWER The HPV vaccine is generally not recommended for use in pregnant women. How...
متن کاملRisk factors for non-initiation of the human papillomavirus vaccine among adolescent survivors of childhood cancer.
Effective vaccination is now available to prevent human papillomavirus (HPV), the most common sexually transmitted infection and cause of cervical cancer. This study aimed to estimate the prevalence of HPV vaccination among childhood cancer survivors and identify factors associated with HPV vaccine initiation and completion. Mothers of daughters of ages 9 to 17 years with/without a history of c...
متن کاملHuman papillomavirus vaccine initiation in an area with elevated rates of cervical cancer.
PURPOSE We assessed human papillomavirus (HPV) vaccination of adolescent girls living in communities with elevated cervical cancer rates. METHODS During July to October 2007, we conducted interviews with a probability sample of parents (or guardians) of 10- to 18-year-old girls in five North Carolina counties with cervical cancer rates substantially higher than the national average. Estimates...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Value in Health
سال: 2016
ISSN: 1098-3015
DOI: 10.1016/j.jval.2016.03.1188